Results 91 to 100 of about 6,730 (183)

Real-world treatment patterns and outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the REAL-AVA 3.5 study. [PDF]

Br J Haematol
Piatek C, Oladapo A, Kolodny S, Vredenburg M, Lucht S, Bland E, Pathak P, Feinberg B, Maitland H.   +8 more
europepmc   +1 more source

Romiplostim N01 accelerates platelet engraftment in autologousstem cell transplantation using non-cryopreserved peripheral blood stem cells for plasma cell neoplasms. [PDF]

Front Immunol
Sheng X, Zheng Q, Xiang J, Dong N, Zhao Y, Hu H, Qian L, Liu W, Shen J, Ye B, Zhang Y.   +10 more
europepmc   +1 more source

Effect of Thrombopoietin Receptor Agonist Romiplostim on the Ionizing Radiation-Induced Premature Aging. [PDF]

Pharmacol Res Perspect
Yamaguchi M, Hirouchi T, Sato Y, Kashiwakura I.   +3 more
europepmc   +1 more source

Personalized Management of Cytopenias in Chronic Liver Disease: From Pathophysiology to Treatment Strategies. [PDF]

JGH Open
Wang X, Fu S, Zhu X, Zhao Y.
europepmc   +1 more source

Primary Sjögren's syndrome-associated immune thrombocytopenia: from pathogenesis to treatment. [PDF]

Front Immunol
Liu C, Zheng Z, He T, Zhang G, Fu G.
europepmc   +1 more source

Editorial: Endothelium, innate immunity and coagulation in hematological disorders. [PDF]

Front Med (Lausanne)
Evangelidis P, Gavriilaki E.
europepmc   +1 more source

Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia. [PDF]

BMC Cancer
Cheng Y, Wei J, Zhu F, Xuan L, Li Y, Meng L, Zhu C, Zhao H.   +7 more
europepmc   +1 more source

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series. [PDF]

Br J Haematol
Balaian E, Alesci RS, Marten S, Georgi JA, Naue C, Bornhäuser M, Trautmann-Grill K.   +6 more
europepmc   +1 more source

Loss of KDEL function from a calreticulin frameshift mutation drives expression of an immature, mutant calreticulin-dependent form of the thrombopoietin receptor MPL. [PDF]

Haematologica
Masubuchi N, Yang Y, Imai M, Kihara Y, Morishita S, Edahiro Y, Komatsu N.   +6 more
europepmc   +1 more source

Utility and Safety of Romiplostim in Pediatric Allogeneic Stem Cell Transplantation. [PDF]

Pediatr Transplant
Senthil S, Moothedath A, Potter JE, Wilkinson HM, Whiteside E, Nataraj R, Mustafa O, Horgan C, Bonney D, Brett S, Wynn R.   +10 more
europepmc   +1 more source